Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancerXuan Lin, Lina Liu, Ying Xie et al.|Translational Oncology|2021Cited by 30